|This PCORI Funding Announcement will open on Tuesday, September 1, 2020, with more information about the funding opportunity.|
Notice of Upcoming PCORI Funding Announcement
The Broad PCORI Funding Announcements (PFAs) seek investigator-initiated applications for patient-centered comparative clinical effectiveness research (CER) projects aligned with our priority areas for research. This PFA covers the following priority areas: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; Communication and Dissemination Research, and Improving Health Systems. These broad areas encompass the patient-centered comparative CER we support.
Priority Research Areas
PCORI’s reauthorizing legislation provided additional direction about national research priorities, noting that they should include research with respect to:
- Intellectual and developmental disabilities
- Maternal mortality
Pending further stakeholder input and elaboration of specific research needs, PCORI invites investigators to submit Letters of Intent (LOIs) for studies comparing clinical and/or health systems interventions to address adverse consequences and outcomes in these two priority areas.
PCORI invites LOIs proposing to examine treatment or management interventions to maximize function and quality of life for individuals living with intellectual and developmental disabilities, and families and caregivers of individuals with intellectual and developmental disabilities. We also invite LOIs that propose interventions to reduce maternal mortality. Consideration also will be given to applications that address disparities in vulnerable populations.
All submissions should address needs of patients, caregivers, clinicians, and other healthcare stakeholders in making personalized clinical decisions across a wide range of conditions, populations, and treatments. Note: In general, PCORI will not cover costs for interventions that are being compared in the proposed study.
Our National Priorities for Research and Research Agenda is a framework to guide our funding of comparative clinical effectiveness research that will give patients and those who care for them the ability to make better-informed health decisions. The framework was developed by workgroups of our Board of Governors, members of our Methodology Committee, and staff.
Reminder: The primary institution’s Administrative Official must review, authorize, and submit the full application by 5 pm ET on January 12, 2021.